Return to search

Koronis Raises $20 Million

Koronis Pharmaceuticals Inc., a Seattle-based developer of antiviral therapeutics, has raised $20 million in Series D funding. Pacific Horizon Ventures led the deal, and was joined by fellow return backer Asset Management Company. www.koronispharma.com